SAN FRANCISCO, Calif-Drugs that were once touted as the cure to cancer have shown only a slight benefit in testing.
The dramatic tumor shrinkage or disappearance that doctors originally predicted from drugs has not happened in trial studies. The three drugs discovered within Judah Folkman's, MD, lab are within a new field pioneered by the physician and his team. Angiogensis, which starves tumors with chemicals and stops them form building new blood vessels, includes endostatin and angiostatin drugs. Both drugs were discovered by Michael O'Reilly, MD.
An article in The New York Times incorrectly labeled these new drugs as a possible cancer cure. However, only in a few cases have the drugs stopped growing cancer. In some cases the drug has halted cancer in some parts of the body, while having little effect elsewhere. The drugs do seem to slow the flow of blood to the patient's tumor.
The researchers will move on with these drugs and see if they are more effective when combined with chemotherapy and radiation.
Information from www.washingtonpost.com
The CDC at a Crossroads: Budget Cuts, Public Health, and the Growing Threat of Infectious Diseases
March 12th 2025Budget cuts to the CDC threaten disease surveillance, outbreak response, and public health programs, increasing risks from measles, avian flu, and future pandemics while straining health care infrastructure nationwide.
Standing Up for Science: A Rally Participant’s Perspective
March 11th 2025Infection Control Today's Editorial Advisory Board member and contributing editor, Heather Stoltzfus, MPH, RN, CIC, recently joined the Stand Up for Science rally in Washington, DC. She gives a first-person perspective on the rally and the rally-goers' strong message.